# White House pulls nomination for FDA nominee Overton

Source: [BioPharma Dive - Latest News](https://www.biopharmadive.com/news/white-house-withdraw-heidi-overton-fda-commissioner-nomination/874961/) · 2026-11-18 · Medicine
Page: https://themorning.science/story/white-house-pulls-nomination-for-fda-nominee-overton-015e02b39611659b
Kind: policy · Impact: medium

## In brief

- The White House has withdrawn its nomination of Heidi Overton to lead the FDA, according to BioPharma Dive on 2026-11-18.
- BioPharma Dive reports that analysts say the withdrawal shouldn't disrupt the agency.
- The end of Overton's candidacy likely means a Democrat-controlled Congress will choose the FDA's next leader.

## Why it matters

FDA leadership is unsettled again, and the agency's next commissioner will shape how it regulates drugs and medical products that science readers follow.

## Timeline

- 2026-11-18: White House withdraws nomination of Heidi Overton as FDA commissioner

## Coverage

- [White House pulls nomination for FDA nominee Overton](https://www.biopharmadive.com/news/white-house-withdraw-heidi-overton-fda-commissioner-nomination/874961/) — BioPharma Dive - Latest News, 2026-11-18

Tags: fda, drug regulation, nominations, us policy, heidi overton

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science
